What Is H. Pylori? H
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Peptic Ulcer Disease
Peptic Ulcer Disease orking with you as a partner in health care, your gastroenterologist Wat GI Associates will determine the best diagnostic and treatment measures for your unique needs. Albert F. Chiemprabha, M.D. Pierce D. Dotherow, M.D. Reed B. Hogan, M.D. James H. Johnston, III, M.D. Ronald P. Kotfila, M.D. Billy W. Long, M.D. Paul B. Milner, M.D. Michelle A. Petro, M.D. Vonda Reeves-Darby, M.D. Matt Runnels, M.D. James Q. Sones, II, M.D. April Ulmer, M.D., Pediatric GI James A. Underwood, Jr., M.D. Chad Wigington, D.O. Mark E. Wilson, M.D. Cindy Haden Wright, M.D. Keith Brown, M.D., Pathologist Samuel Hensley, M.D., Pathologist Jackson Madison Vicksburg 1421 N. State Street, Ste 203 104 Highland Way 1815 Mission 66 Jackson, MS 39202 Madison, MS 39110 Vicksburg, MS 39180 Telephone 601/355-1234 • Fax 601/352-4882 • 800/880-1231 www.msgastrodocs.com ©2010 GI Associates & Endoscopy Center. All rights reserved. A discovery that Table of contents brought relief to millions of ulcer What Is Peptic Ulcer Disease............... 2 patients...... Three Major Types Of Peptic Ulcer Disease .. 6 The bacterium now implicated as a cause of some ulcers How Are Ulcers Treated................... 9 was not noticed in the stomach until 1981. Before that, it was thought that bacteria couldn’t survive in the stomach because Questions & Answers About Peptic Ulcers .. 11 of the presence of acid. Australian pathologists, Drs. Warren and Marshall found differently when they noticed bacteria Ulcers Can Be Stubborn................... 13 while microscopically inspecting biopsies from stomach tissue. -
THE SKY IS the LIMIT for WIND POWER Wind Energy Is One of the Best Sources of Alternative Energy
Mechanical Contractors July— Sept 2018 THE SKY IS THE LIMIT FOR WIND POWER Wind energy is one of the best sources of alternative energy. Wind refers to the movement of air from high pressure areas to low pressure areas. Wind is caused by uneven heating of the earth’s surface by the sun. Hot air rises up and cool air flows in to take its place. Winds will always exist as long as solar energy exists and peo- ple will be able to harness the energy forever. Windmills have been in use since 2000 B.C. and were first developed in Persia and China. Ancient mariners sailed to distant lands by making use of winds. Farmers used wind power to pump water and for grinding grains. Today the most popular use of wind energy is converting it to electrical energy to meet the critical energy needs of the planet. It is a renewable source of energy and does not produce any pollutants or emissions during opera- tion that could harm the environment. Wind power is one of the cleanest and safest method of generating renewable electricity. Wind farms can be created to trap wind energy by placing multiple wind turbines in the same location for the purpose of generating large amounts of electric power. Wind energy is mostly harnessed by wind turbines which are as high as 20 story buildings and usually have three blades which are 60 meters long. They resemble giant airplane propellers mounted on a stick. The blades are spun by the wind which transfers motion to a shaft connected to a generator which produces electricity. -
Pancreatic Cancer
A Patient’s Guide to Pancreatic Cancer COMPREHENSIVE CANCER CENTER Staff of the Comprehensive Cancer Center’s Multidisciplinary Pancreatic Cancer Program provided information for this handbook GI Oncology Program, Patient Education Program, Gastrointestinal Surgery Department, Medical Oncology, Radiation Oncology and Surgical Oncology Digestive System Anatomy Esophagus Liver Stomach Gallbladder Duodenum Colon Pancreas (behind the stomach) Anatomy of the Pancreas Celiac Plexus Pancreatic Duct Common Bile Duct Sphincter of Oddi Head Body Tail Pancreas ii A Patient’s Guide to Pancreatic Cancer ©2012 University of Michigan Comprehensive Cancer Center Table of Contents I. Overview of pancreatic cancer A. Where is the pancreas located?. 1 B. What does the pancreas do? . 2 C. What is cancer and how does it affect the pancreas? .....................2 D. How common is pancreatic cancer and who is at risk?. .3 E. Is pancreatic cancer hereditary? .....................................3 F. What are the symptoms of pancreatic cancer? ..........................4 G. How is pancreatic cancer diagnosed?. 7 H. What are the types of cancer found in the pancreas? .....................9 II. Treatment A. Treatment of Pancreatic Cancer. 11 1. What are the treatment options?. 11 2. How does a patient decide on treatment? ..........................12 3. What factors affect prognosis and recovery?. .12 D. Surgery. 13 1. When is surgery a treatment?. 13 2. What other procedures are done?. .16 E. Radiation therapy . 19 1. What is radiation therapy? ......................................19 2. When is radiation therapy given?. 19 3. What happens at my first appointment? . 20 F. Chemotherapy ..................................................21 1. What is chemotherapy? ........................................21 2. How does chemotherapy work? ..................................21 3. When is chemotherapy given? ...................................21 G. -
Symptoms What Is IBS?
IBS Irritable Bowel Syndrome What is IBS? Symptoms IBS is a functional gut disorder, meaning the normal way the intestine moves, the sensitiv- ity of nerves in the intestine, or the way the brain controls the intestinal functions, is • People with IBS normally experience recurring episodes of diarrhea (IBS-D), constipation (IBS-C) impaired. The exact cause of IBS is still not or a mixture of both (IBS-M), alongside intense understood, but the research suggests a cramping that can last for hours. combination of factors can lead to IBS: family history of IBS, stress, previous gut infections • Symptoms can also include bloating, gas, abdom- and an imbalance in gut bacteria are a few inal distension, intermittent indigestion, nausea, potential causes. and feeling full or uncomfortable after eating. • Some people may have symptoms in their The diagnostic criteria for IBS is defined as throat/upper stomach area, including burping, recurrent abdominal pain or discomfort for at reflux-type symptoms, chest pain and feeling a least 3 days per month for the last 3 months, lump in the throat or stomach. These symptoms with at least two of the following: may indicate functional dyspepsia, which is a functional gut disorder of the upper digestive tract related to IBS. • Improvement of symptoms with Talk to your doctor about differentiating between defecation the two based on your symptoms. • Symptom onset associated with a change in the frequency of stool Did you know? • Symptom onset associated with a IBS is the most common functional digestive change in the form/appearance of stool disorder, affecting between 13-20% of Canadians. -
Irritable Bowel Syndrome (IBS) Primary Care Pathway
Irritable Bowel Syndrome (IBS) Primary Care Pathway Quick links: Pathway primer Expanded details Advice options Patient pathway 1. Suspected IBS Recurrent abdominal pain at least one day per week (on average) in the last 3 months, with two or more of the following: • Related to defecation (either increasing or improving pain) • Associated with a change in frequency of stool • Associated with a change in form (appearance) of stool Typical Features of IBS • Intestinal: bloating, flatulence, nausea, burping, early satiety, dyspepsia • Extra intestinal: dysuria, frequent/urgent urination, widespread musculoskeletal pain, dysmenorrhea, dyspareunia, fatigue, anxiety, depression Positive 2. Initial workup for celiac • Medical history, physical exam, assess secondary causes of symptoms • Serological screening to exclude celiac • CBC, Ferritin 6. Refer for consultation and/or endoscopy 3. Alarm features Yes • Family history of IBD or colorectal cancer (first degree) • GI bleeding/anemia • Nocturnal symptoms • Onset after age 50 • Unintended weight loss (>5% over 6-12 months) No Presumed Diagnosis of IBS 4. Potential approaches to IBS treament (all subtypes) • Dietary modifications: assess common food triggers, psyllium supplementation (soluble fibre), ensure adequate fluids • Physical activity: 20+ minutes of exercise almost daily; aiming for 150 min/week • Psychological treatment: patient counselling and reassurance, Cognitive Behavioural Therapy, hypnotherapy, screen and treat any underlying sleep or mood disorder where relevant • Pharmacologic therapy: antispasmodics (hyoscine butylbromide, dicyclomine hydrochloride, pinaverium bromide), enteric coated peppermint oil 5. Specific approaches based on IBS subtypes IBS-D IBS-M/U IBS-C (diarrhea predominant) (mixed/undefined) (constipation predominant) Further testing for patients • Loperamide • Pay particular attention to • Adequate fibre and water with high clinical suspicion of • Tricyclic antidepressants lifestyle & dietary principles intake IBD. -
Active Peptic Ulcer Disease in Patients with Hepatitis C Virus-Related Cirrhosis: the Role of Helicobacter Pylori Infection and Portal Hypertensive Gastropathy
dore.qxd 7/19/2004 11:24 AM Page 521 View metadata, citation and similar papers at core.ac.uk ORIGINAL ARTICLE brought to you by CORE provided by Crossref Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: The role of Helicobacter pylori infection and portal hypertensive gastropathy Maria Pina Dore MD PhD, Daniela Mura MD, Stefania Deledda MD, Emmanouil Maragkoudakis MD, Antonella Pironti MD, Giuseppe Realdi MD MP Dore, D Mura, S Deledda, E Maragkoudakis, Ulcère gastroduodénal évolutif chez les A Pironti, G Realdi. Active peptic ulcer disease in patients patients atteints de cirrhose liée au HCV : Le with hepatitis C virus-related cirrhosis: The role of Helicobacter pylori infection and portal hypertensive rôle de l’infection à Helicobacter pylori et de la gastropathy. Can J Gastroenterol 2004;18(8):521-524. gastropathie liée à l’hypertension portale BACKGROUND & AIM: The relationship between Helicobacter HISTORIQUE ET BUT : Le lien entre l’infection à Helicobacter pylori pylori infection and peptic ulcer disease in cirrhosis remains contro- et l’ulcère gastroduodénal dans la cirrhose reste controversé. Le but de la versial. The purpose of the present study was to investigate the role of présente étude est de vérifier le rôle de l’infection à H. pylori et de la gas- H pylori infection and portal hypertension gastropathy in the preva- tropathie liée à l’hypertension portale dans la prévalence de l’ulcère gas- lence of active peptic ulcer among dyspeptic patients with compen- troduodénal évolutif chez les patients dyspeptiques souffrant d’une sated hepatitis C virus (HCV)-related cirrhosis. -
Challenges in the Management of Acute Peptic Ulcer Bleeding
Review Challenges in the management of acute peptic ulcer bleeding James Y W Lau, Alan Barkun, Dai-ming Fan, Ernst J Kuipers, Yun-sheng Yang, Francis K L Chan Acute upper gastrointestinal bleeding is a common medical emergency worldwide, a major cause of which are bleeding Lancet 2013; 381: 2033–43 peptic ulcers. Endoscopic treatment and acid suppression with proton-pump inhibitors are cornerstones in the Institute of Digestive Diseases, management of the disease, and both treatments have been shown to reduce mortality. The role of emergency surgery The Chinese University of Hong continues to diminish. In specialised centres, radiological intervention is increasingly used in patients with severe and Kong, Hong Kong, China (Prof J Y W Lau MD, recurrent bleeding who do not respond to endoscopic treatment. Despite these advances, mortality from the disorder Prof F K L Chan MD); Division of has remained at around 10%. The disease often occurs in elderly patients with frequent comorbidities who use Gastroenterology, McGill antiplatelet agents, non-steroidal anti-infl ammatory drugs, and anticoagulants. The management of such patients, University and the McGill especially those at high cardiothrombotic risk who are on anticoagulants, is a challenge for clinicians. We summarise University Health Centre, Quebec, Canada the published scientifi c literature about the management of patients with bleeding peptic ulcers, identify directions for (Prof A Barkun MD); Institute of future clinical research, and suggest how mortality can be reduced. Digestive Diseases, Xijing Hospital, Fourth Military Introduction by how participants were sampled, their inclusion Medical University, Xian, China (Prof D Fan MD); Department of Acute upper gastrointestinal bleeding is characterised by criteria, and defi nitions of case ascertainment. -
An Overview: Current Clinical Guidelines for the Evaluation, Diagnosis, Treatment, and Management of Dyspepsia$
Osteopathic Family Physician (2013) 5, 79–85 An overview: Current clinical guidelines for the evaluation, diagnosis, treatment, and management of dyspepsia$ Peter Zajac, DO, FACOFP, Abigail Holbrook, OMS IV, Maria E. Super, OMS IV, Manuel Vogt, OMS IV From University of Pikeville-Kentucky College of Osteopathic Medicine (UP-KYCOM), Pikeville, KY. KEYWORDS: Dyspeptic symptoms are very common in the general population. Expert consensus has proposed to Dyspepsia; define dyspepsia as pain or discomfort centered in the upper abdomen. The more common causes of Functional dyspepsia dyspepsia include peptic ulcer disease, gastritis, and gastroesophageal reflux disease.4 At some point in (FD); life most individuals will experience some sort of transient epigastric pain. This paper will provide an Gastritis; overview of the current guidelines for the evaluation, diagnosis, treatment, and management of Gastroesophageal dyspepsia in a clinical setting. reflux disease (GERD); r 2013 Elsevier Ltd All rights reserved. Nonulcer dyspepsia (NUD); Osteopathic manipulative medicine (OMM); Peptic ulcer disease (PUD); Somatic dysfunction Dyspeptic symptoms are very common in the general common causes of dyspepsia include peptic ulcer disease population, affecting an estimated 20% of persons in the (PUD), gastritis, and gastroesophageal reflux disease United States.1 While a good number of these individuals (GERD).4 However, it is not unusual for a complete may never seek medical care, a significant proportion will investigation to fail to reveal significant organic findings, eventually proceed to see their family physician. Several and the patient is then considered to have “functional reports exist on the prevalence and impact of dyspepsia in the dyspepsia.”5,6 The term “functional” is usually applied to general population.2,3 However, the results of these studies disorders or syndromes where the body’s normal activities in are strongly influenced by criteria used to define dyspepsia. -
2019 FMX Gastrointestinal Handouts
2019 FMX Gastrointestinal Handouts Colorectal Cancer Update: Butt Seriously (CME064‐065) Diverticulitis Update (CME066‐067) Gallbladder Disease (CME068‐069) Gastroesophageal Reflux Disease: Evidence‐Based Approach (CME070‐071) Colorectal Cancer Update: Butt Seriously Jason Domagalski, MD, FAAFP ACTIVITY DISCLAIMER The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note that medical information is constantly changing; the information contained in this activity was accurate at the time of publication. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed. Rather, it is intended to present an approach, view, statement, or opinion of the faculty, which may be helpful to others who face similar situations. The AAFP disclaims any and all liability for injury or other damages resulting to any individual using this material and for all claims that might arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by a physician or any other person. Physicians may care to check specific details such as drug doses and contraindications, etc., in standard sources prior to clinical application. This material might contain recommendations/guidelines developed by other organizations. Please note that although these guidelines might be included, this does not necessarily imply the endorsement by the AAFP. 1 DISCLOSURE It is the policy of the AAFP that all individuals in a position to control content disclose any relationships with commercial interests upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflict of interest (COI), and if identified, conflicts are resolved prior to confirmation of participation. -
Leading Article Vaccines Against Gut Pathogens
Gut 1999;45:633–635 633 Gut: first published as 10.1136/gut.45.5.633 on 1 November 1999. Downloaded from Leading article Vaccines against gut pathogens Many infectious agents enter the body using the oral route development.15 Salmonella strains harbouring mutations and are able to establish infections in or through the gut. in genes of the shikimate pathway (aro genes) have For protection against most pathogens we rely on impaired ability to grow in mammalian tissues (they are immunity to prevent or limit infection. The expression of starved in vivo for the aromatic ring).6 Salmonella strains protective immunity in the gut is normally dependent both harbouring mutations in one or two aro genes (i.e., aroA, on local (mucosal) and systemic mechanisms. In order to aroC ) are eVective vaccines in several animal models after obtain full protection against some pathogens, particularly single dose oral administration and induce strong Th1 type non-invasive micro-organisms such as Vibrio cholerae, and mucosal responses.7 An aroC/aroD mutant of S typhi mucosal immunity may be particularly important. There is was well tolerated clinically in human volunteers; mild a need to take these factors into account when designing transient bacteraemia in a minority of the subjects was the vaccines targeting gut pathogens. Conventional parenteral only drawback.8 Th1 responses, cytotoxic T lymphocyte vaccines (injected vaccines) can induce a degree of responses, and IgG, IgA secreting gut derived lymphocytes systemic immunity but are generally poor stimulators of appeared in the majority of vaccinees.89 In an attempt to mucosal responses. -
What Is a Paraesophageal Hernia?
JAMA PATIENT PAGE What Is a Paraesophageal Hernia? A paraesophageal hernia occurs when the lower part of the esophagus, the stomach, or other organs move up into the chest. The hiatus is an opening in the diaphragm (a muscle separating the chest from the abdomen) through which organs pass from the Paraesophageal or hiatal hernia The junction between the esophagus and the stomach (the gastroesophageal chest into the abdomen. The lower part of the esophagus and or GE junction) or other organs move from the abdomen into the chest. the stomach normally reside in the abdomen, just under the dia- phragm. The gastroesophageal (GE) junction is the area where Normal location of the esophagus, Type I hiatal hernia (sliding hernia) with the GE junction and stomach The GE junction slides through the the esophagus connects with the stomach and is usually located in the abdominal cavity diaphragmatic hiatus to an abnormal 1to2inchesbelowthediaphragm.Ahiatalorparaesophagealhernia position in the chest. occurs when the GE junction, the stomach, or other abdominal or- Esophagus gans such as the small intestine, colon, or spleen move up into the GE junction chest where they do not belong. There are several types of para- Hiatus esophagealhernias.TypeIisahiatalherniaorslidinghernia,inwhich the GE junction moves above the diaphragm, leaving the stomach in D I A P H R A the abdomen; this represents 95% of all paraesophageal hernias. G M Types II, III, and IV occur when part or all of the stomach and some- S T O M A C H times other organs move up into the chest. Common Symptoms of Paraesophageal Hernia More than half of the population has a hiatal or paraesophageal Less common types of paraesophageal hernias are classified based on the extent hernia. -
Cystic Fibrosis Patients: Now They Are Adults
Gastrointestinal, Hepatic, and Nutritional Challenges in FA Sarah Jane Schwarzenberg, MD Pediatric Gastroenterology, Hepatology and Nutrition June 29, 2014 GI problems in FA • 5% have gastrointestinal tract abnormalities • Common gastrointestinal concerns – Poor oral intake – Nausea – Abdominal pain – Diarrhea • GI and liver complications of treatment • Complications of stem cell transplant Routine GI/Nutrition care • Evaluate height and weight at each clinical visit • Screen for gastrointestinal problems – Abdominal pain – Nausea and vomiting – Constipation or diarrhea – Excessive bowel gas • Consider seeing a gastroenterologist if these problems do not respond to initial management Preparing for a clinical visit • Abdominal pain? – Location – Inciting agents • Nausea and vomiting? – Time of day – Association with drugs or food • Excessive gas? A simple symptom diary for 1-3 months may help pinpoint the problem Some conditions causing GI symptoms • Complications of anatomic gastrointestinal abnormalities – Strictures – Obstructions • Chronic inflammation/infection – Diarrheal disease – Small bowel overgrowth – Urinary tract infections • Medication side effects • Neurologic/behavioral problems Gastroesophageal reflux • Commonly associated with esophageal atresia (TEF) • Commonly seen in children without TEF • Reflux may become more common with age • Medical management is essential to reduce complications • Many require anti-reflux surgery Symptoms of GER • Heartburn • Abdominal pain • Excessive burping, hiccuping • Poor appetite, vomiting